APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 66 filers reported holding APREA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,620 | -48.9% | 310,029 | +0.1% | 0.00% | – |
| Q3 2022 | $201,000 | -24.4% | 309,598 | -12.9% | 0.00% | – |
| Q2 2022 | $266,000 | -59.8% | 355,490 | 0.0% | 0.00% | – |
| Q1 2022 | $662,000 | -66.9% | 355,490 | -49.0% | 0.00% | – |
| Q4 2021 | $2,000,000 | -45.4% | 696,826 | -2.9% | 0.00% | – |
| Q3 2021 | $3,665,000 | +6.1% | 717,415 | +1.4% | 0.00% | – |
| Q2 2021 | $3,453,000 | -10.1% | 707,422 | -6.0% | 0.00% | – |
| Q1 2021 | $3,839,000 | +4.1% | 752,734 | +0.4% | 0.00% | – |
| Q4 2020 | $3,688,000 | -76.2% | 749,714 | +16.6% | 0.00% | -100.0% |
| Q3 2020 | $15,475,000 | -34.0% | 643,190 | +6.4% | 0.00% | 0.0% |
| Q2 2020 | $23,438,000 | +151.2% | 604,377 | +125.1% | 0.00% | – |
| Q1 2020 | $9,331,000 | -22.4% | 268,451 | +2.5% | 0.00% | – |
| Q4 2019 | $12,023,000 | – | 261,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Princeton Global Asset Management LLC | 100 | $444 | 0.00% |
| Quent Capital, LLC | 3 | $13 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |